I am not a expert in biotechnology and have never claim to be. But you don't need this type of experience to be successful at investing. You need to separate the two. There are two parts to this: The science and the stock. I find most Scientists and Brainiac's to lack the common sense. I know the ins and outs of Wall Street, thats all I need to know. NW is not viewed by Wall Street as world beaters, I can tell you that. The lack of execution and a well thought out plan is what is killing the SP. Wall Street hates uncertainty, it hates indecision, it hates poor management, it hates missed deadlines, it hates massively diluted common shares, and hates not knowing what comes next. Surprise. These are all attributes of Northwest Bio. Its no surprise the SP is stuck in the .30s. Fair or unfair this is just the way it is in the world of investing. There are some very smart folks pulling the punches in our financial markets...some good, some bad, but all very, very smart. Are you telling me they are ALL missing this and we are all smarter than them?? Think about that. The reasons I listed above are true and why WS has not taken a large stake in NW and most wont touch it, even with UK approval. Even the best technology can be squandered by piss-poor management. Elite Management is needed to maximize DCVax, and this old and tired group with NW isnt "cutting the mustard" for WS. I can 100% guarantee if the helm at NW was handed over to someone that WS was confident in and had major experience bringing drugs/vaccines from the clinic to commercialization, the SP would turn on a dime. Les Goldman and the Big-Biz show just wont do it.
Market Data 
Markets 
AI
